2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow Maintenance Therapy: new trials by email Literature Review of Maintenance Therapy trials Research Report on Maintenance Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib Gilteritinib, Sorafenib - Acute Myeloid Leukemia (AML), FLT3-ITD Mutation | Phase 3 | Recruiting | The First Affiliated Hospital of Soochow University | 594 | 2026-05-01 | 2026-03-20 |
| Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma Maintenance Therapy with Toripalimab and Capecitabine, Maintenance Therapy with Capecitabine - Nasopharyngeal Carcinoma, High-Risk Cancer | Phase 3 | Recruiting | Jiangxi Provincial Cancer Hospital | 264 | 2024-03-07 | 2026-05-15 |
Leukemia, Myeloid, Acute (1) · Nasopharyngeal Carcinoma (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Carcinoma (1) · Head and Neck Neoplasms (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukemia (1) · Leukemia, Myeloid (1) · Nasopharyngeal Diseases (1) · Nasopharyngeal Neoplasms (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Otorhinolaryngologic Diseases (1) · Otorhinolaryngologic Neoplasms (1) · Pharyngeal Diseases (1)
Capecitabine (1) · Maintenance (1) · Sorafenib (1) · gilteritinib (1) · toripalimab (1)
Jiangxi Provincial Cancer Hospital (1) · The First Affiliated Hospital of Soochow University (1)
China (2)
Jingao Li (1)